Epstein Secrets

torture, the surprising liberalism of generals, and the stupidity of the civilian-military bureaucracy. Then it was on to the looming appointment of Michael Flynn—a favorite Trump general who’d been the opening act at many Trump rallies—as the National Security Advisor. “He’s fine. He’s not Jim Mattis and he’s

r. Bolton was an Ailes favorite, too. “He’s a bomb thrower,” said Ailes. “And a strange little fucker. But you need him. Who else is good on Israel? Flynn is a little nutty on Iran. Tillerson”—the secretary of state designate—“just knows oil.” HOUSE_OVERSIGHT_019885 “Bolton’s mustache is a problem,” s

the National Security Advisor. “Yes,” she said, “General Flynn does enjoy the full confidence of the president.”

a helicopter from their Long Island estate out to a scheduled fundraiser—with other potential donors bailing by the second—at New York Jets owner and Johnson & Johnson heir Woody Johnson’s summer house in the Hamptons. Trump had no real relationship with either father or daughter. He’d had only a few conversations

iming charges against him stem from a politically motivated selective prosecution. Order attached I Read full article » Man Accused Of Threatening Flynn Judge Reaches Plea Deal A New York man will plead guilty to charges that he threatened to assault and murder a D.C. federal judge who oversaw the c

he threatened to assault and murder a D.C. federal judge who oversaw the criminal case of President Donald Trump's former national security adviser Michael Flynn, a federal prosecutor revealed on Monday. Read full article » Weinstein Accusers Get Case Paused To Attempt Mediation A New York federal judge on

Bard Inc. Chevron Corp. Deutsche Bank AG Dick's Sporting Goods Inc. Facebook Inc. Georgetown University International Business Machines Corp. Johnson & Johnson Judicial Watch Inc. Kinney Recruiting LLC LexisNexis Group Madison Square Garden Entertainment Group LLC Marriott Vacations Worldwide Corp. Ma

against former National Security Adviser Michael Flynn despite his guilty plea have commanded more nati

Trump's decision to commute Roger Stone's prison sentence and "the Department of Justice dropping its case against former National Security Adviser Michael Flynn despite his guilty plea have commanded more national attention. But outspoken critics, including Cohen and celebrity attorney Michael Avenatti, may

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

against former National Security Adviser Michael Flynn despite his guilty plea have commanded more nati

Trump's decision to commute Roger Stone's prison sentence and "the Department of Justice dropping its case against former National Security Adviser Michael Flynn despite his guilty plea have commanded more national attention. But outspoken critics, including Cohen and celebrity attorney Michael Avenatti, may

s-may- ready-early-2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guid

US District Judge Emmet G. Sullivan's plan to examine" the Justice Department's decision to drop its case against former national security adviser Michael Flynn, thereby "reviving the unusual case testing the limits of the judiciary's power to check the executive branch." The Post adds "the decision to rehea

livan to immediately dismiss the case and said Sullivan was wrong to appoint a retired federal judge to argue against the government's move to undo Flynn's guilty plea." Politico <https://www.politico.com/news/2020/07/30/appeals-court-michael- flynn-388384> (7/30, Gerstein, Cheney, 4.29M) says Thursday

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

US District Judge Emmet G. Sullivan's plan to examine" the Justice Department's decision to drop its case against former national security adviser Michael Flynn, thereby "reviving the unusual case testing the limits of the judiciary's EFTA00150168 power to check the executive branch." The Post adds "the de

llivan to immediately dismiss the case and said Sullivan was wrong to appoint a retired federal judge to argue against the government's move to undo Flynn's guilty plea." Politico (7/30, Gerstein, Cheney, 4.29M) says Thursday's announcement is "a setback for Flynn, who scored an unexpected victory on

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

Trump's decision to commute Roger Stone's prison sentence and "the Department of Justice dropping its case against former National Security Adviser Michael Flynn despite his guilty plea have commanded more national attention. But outspoken critics, including Cohen and celebrity attorney Michael Avenatti, may

against former National Security Adviser Michael Flynn despite his guilty plea have commanded more nati

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

Trump's decision to commute Roger Stone's prison sentence and "the Department of Justice dropping its case against former National Security Adviser Michael Flynn despite his guilty plea have commanded more national attention. But outspoken critics, including Cohen and celebrity attorney Michael Avenatti, may

against former National Security Adviser Michael Flynn despite his guilty plea have commanded more nati

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

US District Judge Emmet G. Sullivan's plan to examine" the Justice Department's decision to drop its case against former national security adviser Michael Flynn, thereby "reviving the unusual case testing the limits of the judiciary's power to check the executive branch." The Post adds "the decision to rehea

llivan to immediately dismiss the case and said Sullivan was wrong to appoint a retired federal judge to argue against the government's move to undo Flynn's guilty plea." Politico (7/30, Gerstein, Cheney, 4.29M) says Thursday's announcement is "a setback for Flynn, who scored an unexpected victory on

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

leaving the National Mall, Capitol Hill, the White House and some other federal property under congressional control." The Washington Post (4/22, Flynn, 10.52M) reports that the bill, "symbolically titled H.R. 51, now heads to the Senate, where proponents hope to break new ground - including a first

ine Use. The Washington Post (4/22, Al, McGinley, Sun, 10.52M) reports, "Federal health authorities are leaning toward recommending that use of the Johnson & Johnson coronavirus vaccine resume, possibly as soon as this weekend - a move that would include a new warning about a rare complication involving blood cl